Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

3.128.188.223
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Metabolic
Movement Disorders

Rare metabolic disorder mimics ADHD in adult patient

Posted on

A recent case report highlights the diagnostic challenges of cerebrotendinous xanthomatosis (CTX), a rare genetic disorder affecting lipid metabolism, which initially presented as attention-deficit/hyperactivity disorder (ADHD) in a 33-year-old patient.

The patient sought psychiatric evaluation due to increasing distractibility and inattention, suspecting adult ADHD. However, the absence of childhood ADHD history, along with neurological symptoms and tendon xanthomas, prompted further investigation. Advanced testing, including neuroimaging and genetic analysis, confirmed a diagnosis of CTX.

Treatment with chenodeoxycholic acid helped stabilize cognitive function, though motor symptoms showed limited improvement.

Reference
Kim J, Hong YJ, Lee SB, et al. Case report: Cerebrotendinous Xanthomatosis masquerading as adult ADHD in psychiatric practice. Front Psychiatry. 2025;16:1528204. doi: 10.3389/fpsyt.2025.1528204. PMID: 39967585; PMCID: PMC11832511.

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-